Hospital Epidemiology and Infection Control in Acute-Care Settings
暂无分享,去创建一个
[1] Jane D. Single.... Management of Multidrug- resistant organisms in Healthcare settings , 2013 .
[2] N. Fishman,et al. Healthcare Infection Control Practices Advisory Committee , 2012 .
[3] Kelly D Peterson,et al. National Healthcare Safety Network (NHSN) report, data summary for 2009, device-associated module. , 2011, American journal of infection control.
[4] M. Bugiani,et al. Tuberculosis among Health Care Workers , 2011, Emerging infectious diseases.
[5] G. Cornaglia,et al. New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[6] P. Krishnan,et al. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. , 2010, The Journal of antimicrobial chemotherapy.
[7] R. Rakita,et al. Mandatory Influenza Vaccination of Healthcare Workers: A 5-Year Study , 2010, Infection Control & Hospital Epidemiology.
[8] N. Woodford,et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.
[9] Ellen Jo Baron,et al. Impact of Strain Type on Detection of Toxigenic Clostridium difficile: Comparison of Molecular Diagnostic and Enzyme Immunoassay Approaches , 2010, Journal of Clinical Microbiology.
[10] Lee H. Harrison,et al. Health care-associated invasive MRSA infections, 2005-2008. , 2010, JAMA.
[11] Wei-hua Zhao,et al. β-Lactamases identified in clinical isolates of Pseudomonas aeruginosa , 2010, Critical reviews in microbiology.
[12] S. Nseir,et al. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[13] A. Muir,et al. New Delhi metallo-beta-lactamase: a cautionary tale. , 2010, The Journal of hospital infection.
[14] M. Wilcox,et al. The potential for airborne dispersal of Clostridium difficile from symptomatic patients. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] L. Miller,et al. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[16] A. Hidrón,et al. Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008 , 2010, Infection Control & Hospital Epidemiology.
[17] D. Gerding,et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control & Hospital Epidemiology.
[18] Michael Y. Lin,et al. Successful Control of an Outbreak of Klebsiella pneumoniae Carbapenemase—Producing K. pneumoniae at a Long-Term Acute Care Hospital , 2010, Infection Control & Hospital Epidemiology.
[19] W. C. Dunagan,et al. Mandatory influenza vaccination of health care workers: translating policy to practice. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] D. Henderson,et al. Infection control guidelines for prevention of health care-associated transmission of hepatitis B and C viruses. , 2010, Clinics in liver disease.
[21] T. Perl,et al. Health care workers as source of hepatitis B and C virus transmission. , 2010, Clinics in liver disease.
[22] Y. Carmeli,et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[23] Michael C. Mosier,et al. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. , 2010, The New England journal of medicine.
[24] C. Grady,et al. SHEA Guideline for Management of Healthcare Workers Who Are Infected with Hepatitis B Virus, Hepatitis C Virus, and/or Human Immunodeficiency Virus , 2010, Infection Control & Hospital Epidemiology.
[25] A. Troelstra,et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. , 2010, The New England journal of medicine.
[26] Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase - United States, 2010. , 2010, MMWR. Morbidity and mortality weekly report.
[27] Raymond Tellier,et al. Aerosol transmission of influenza A virus: a review of new studies , 2009, Journal of The Royal Society Interface.
[28] R. Skov,et al. Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections. , 2009, The Journal of hospital infection.
[29] Sylvia Chong,et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. , 2009, JAMA.
[30] Bala Hota,et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] K. Sepkowitz,et al. Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated , 2009, Bone Marrow Transplantation.
[32] Timothy R. Walsh,et al. Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.
[33] R. Venezia,et al. The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit. , 2009, The Journal of infectious diseases.
[34] J. Ferguson,et al. Preventing healthcare-associated infection: risks, healthcare systems and behaviour. , 2009, Internal medicine journal.
[35] P. Hawkey,et al. The changing epidemiology of resistance. , 2009, The Journal of antimicrobial chemotherapy.
[36] M. Ardo,et al. A Case–Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure , 2009 .
[37] A. Amin. Clinical and economic consequences of ventilator-associated pneumonia. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] L. Munoz-Price,et al. Long-term acute care hospitals. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] J. Beaumont,et al. Topical Therapy for Methicillin-Resistant Staphylococcus aureus Colonization Impact on Infection Risk , 2009, Infection Control & Hospital Epidemiology.
[40] E. Larson,et al. Staffing and structure of infection prevention and control programs. , 2009, American journal of infection control.
[41] A. Wasley,et al. Surveillance for acute viral hepatitis - United States, 2007. , 2009, Morbidity and mortality weekly report. Surveillance summaries.
[42] L. B. Palmer,et al. Ventilator-associated infection , 2009, Current opinion in pulmonary medicine.
[43] C. O'Malley. Infection control in cystic fibrosis: cohorting, cross-contamination, and the respiratory therapist. , 2009, Respiratory care.
[44] Stefan Gravenstein,et al. Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] M. Augenbraun,et al. Success of an Infection Control Program to Reduce the Spread of Carbapenem-Resistant Klebsiella pneumoniae , 2009, Infection Control & Hospital Epidemiology.
[46] Julian I. Rood,et al. Toxin B is essential for virulence of Clostridium difficile , 2009, Nature.
[47] D. Ost,et al. What Are the Important Risk Factors for Healthcare-Associated Pneumonia? , 2009, Seminars in respiratory and critical care medicine.
[48] M. Zilberberg,et al. Secular Trends of Hospitalization With Vancomycin-Resistant Enterococcus Infection in the United States, 2000–2006 , 2009, Infection Control & Hospital Epidemiology.
[49] E. Dubberke,et al. Review of Current Literature on the Economic Burden of Clostridium difficile Infection , 2009, Infection Control & Hospital Epidemiology.
[50] Pesus Chou,et al. Incidence Rate and Variable Cost of Nosocomial Infections in Different Types of Intensive Care Units , 2009, Infection Control & Hospital Epidemiology.
[51] Kelly D Peterson,et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. , 2008, American journal of infection control.
[52] K. Shine,et al. Respiratory Protection for Healthcare Workers in the Workplace Against Novel H1N1 Influenza A: A Letter Report , 2009 .
[53] A. Moreno,et al. Risk factors and management of Gram-positive bacteraemia. , 2009, International journal of antimicrobial agents.
[54] Iraida E. Robledo,et al. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. , 2009, MMWR. Morbidity and mortality weekly report.
[55] E. Krisiunas. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel. , 2009, Mississippi RN.
[56] T. Perl,et al. Healthcare epidemiology: gastrointestinal flu: norovirus in health care and long-term care facilities. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[57] M. Rupp,et al. Improving Cleaning of the Environment Surrounding Patients in 36 Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[58] R. Skov,et al. Emergence and Characterization of Community-Associated Methicillin-Resistant Staphyloccocus aureus Infections in Denmark, 1999 to 2006 , 2008, Journal of Clinical Microbiology.
[59] A. Hidrón,et al. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 , 2008, Infection Control & Hospital Epidemiology.
[60] K. Garey,et al. Peripartum Clostridium difficile infection: case series and review of the literature. , 2008, American journal of obstetrics and gynecology.
[61] Helen Burstin,et al. Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[62] D. Classen,et al. Introduction: Improving Patient Safety Through Infection Control: A New Healthcare Imperative , 2008, Infection Control & Hospital Epidemiology.
[63] Helen Burstin,et al. Strategies to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[64] Helen Burstin,et al. Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[65] S. Saint,et al. Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[66] S. Saint,et al. Strategies to Prevent Catheter-Associated Urinary Tract Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[67] Helen Burstin,et al. Strategies to Prevent Surgical Site Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[68] S. Saint,et al. Strategies to Prevent Central Line–Associated Bloodstream Infections in Acute Care Hospitals , 2008, Infection Control & Hospital Epidemiology.
[69] D. Paterson. Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[70] H. Maltezou. Nosocomial influenza: new concepts and practice , 2008, Current opinion in infectious diseases.
[71] John M Boyce,et al. Impact of Hydrogen Peroxide Vapor Room Decontamination on Clostridium difficile Environmental Contamination and Transmission in a Healthcare Setting , 2008, Infection Control & Hospital Epidemiology.
[72] Margaret A Dudeck,et al. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.
[73] H. Boucher,et al. Epidemiology of methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[74] M. Edmond,et al. Who is steering the ship? External influences on infection control programs. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[75] Fred C Tenover,et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. , 2008, The Journal of infectious diseases.
[76] Lisa L Maragakis,et al. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[77] George Miller,et al. Responding to Simulated Pandemic Influenza in San Antonio, Texas , 2008, Infection Control & Hospital Epidemiology.
[78] A. McGeer,et al. Factors Associated With Acquisition of Vancomycin-Resistant Enterococci (VRE) in Roommate Contacts of Patients Colonized or Infected with VRE in a Tertiary Care Hospital , 2008, Infection Control & Hospital Epidemiology.
[79] A. Wasley,et al. Surveillance for acute viral hepatitis--United States, 2006. , 2008, Morbidity and mortality weekly report. Surveillance summaries.
[80] Bala Hota,et al. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[81] Hugo Sax,et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. , 2008, JAMA.
[82] K. Bush,et al. Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2008, Antimicrobial Agents and Chemotherapy.
[83] A. Cruz,et al. Rapid assays for the diagnosis of influenza A and B viruses in patients evaluated at a large tertiary care children's hospital during two consecutive winter seasons. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[84] E. Tacconelli,et al. Vancomycin-resistant enterococci (VRE): transmission and control. , 2008, International journal of antimicrobial agents.
[85] P. Tambyah,et al. [European and Asian guidelines on management and prevention of catheter-associated urinary tract infections]. , 2008, Urologiia.
[86] D. Nicolau,et al. The Current State of Multidrug‐Resistant Gram‐Negative Bacilli in North America , 2008, Pharmacotherapy.
[87] P. Barss,et al. Nosocomial HIV infection: epidemiology and prevention--a global perspective. , 2008, AIDS reviews.
[88] J. Beaumont,et al. Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals , 2008, Annals of Internal Medicine.
[89] W. Rutala,et al. Guideline for disinfection and sterilization in healthcare facilities, 2008 , 2008 .
[90] J. Fishman. Infection in solid-organ transplant recipients. , 2007, The New England journal of medicine.
[91] H. Wald,et al. Nonpayment for harms resulting from medical care: catheter-associated urinary tract infections. , 2007, JAMA.
[92] Yehuda Carmeli,et al. Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli , 2007, Antimicrobial Agents and Chemotherapy.
[93] E. Lautenbach,et al. Resistant gram-negative bacilli: A neglected healthcare crisis? , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[94] M. Jackson,et al. Management of multidrug-resistant organisms in health care settings, 2006. , 2007, American journal of infection control.
[95] M. Jackson,et al. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings , 2007, American Journal of Infection Control.
[96] J. Morris,et al. Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[97] D. Warren,et al. Initial inappropriate urinary catheters use in a tertiary-care center: incidence, risk factors, and outcomes. , 2007, American journal of infection control.
[98] Roberta B Carey,et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.
[99] J Jaime Caro,et al. The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. , 2007, Infection control and hospital epidemiology.
[100] S. Cosgrove,et al. Outbreak management and implications of a nosocomial norovirus outbreak. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[101] S. Cosgrove,et al. Raising Standards While Watching the Bottom Line Making a Business Case for Infection Control , 2007, Infection Control & Hospital Epidemiology.
[102] Mahbubur Rahman,et al. Performance of Directigen flu A+B enzyme immunoassay and direct fluorescent assay for detection of influenza infection during the 2004-2005 season. , 2007, Diagnostic microbiology and infectious disease.
[103] C. Bridges,et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. , 2007, Vaccine.
[104] Y. Carmeli,et al. Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital , 2007, Antimicrobial Agents and Chemotherapy.
[105] T. Noakes,et al. Semmelweis and the aetiology of puerperal sepsis 160 years on: an historical review , 2007, Epidemiology and Infection.
[106] W. Jarvis. The Lowbury Lecture. The United States approach to strategies in the battle against healthcare-associated infections, 2006: transitioning from benchmarking to zero tolerance and clinician accountability. , 2007, The Journal of hospital infection.
[107] I. Barr,et al. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[108] B. Spellberg,et al. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. , 2007, Medical mycology.
[109] K. Ahmad. Kazakhstan health workers stand trial for HIV outbreak. , 2007, The Lancet. Infectious diseases.
[110] L. Finelli,et al. Surveillance for acute viral hepatitis--United States, 2005. , 2007, Morbidity and mortality weekly report. Surveillance summaries.
[111] J. Morris,et al. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. , 2007, American journal of infection control.
[112] M. Zhan,et al. Comparison of Mortality Risk Associated With Bacteremia Due to Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus , 2007, Infection Control & Hospital Epidemiology.
[113] Susan S. Huang,et al. Legislative Mandates for Use of Active Surveillance Cultures to Screen for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci: Position Statement From the Joint SHEA and APIC Task Force , 2007, Infection Control & Hospital Epidemiology.
[114] Richard Platt,et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. , 2007, The Journal of infectious diseases.
[115] A. Kiss,et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[116] H. Evans,et al. Cost of Gram‐negative resistance* , 2007, Critical care medicine.
[117] M. Jackson,et al. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. , 2007 .
[118] Roger I Glass,et al. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[119] P. Pronovost,et al. An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.
[120] J. Iskander,et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices , 2006, MMWR Recommendations and Reports.
[121] J. Bartlett. Narrative Review: The New Epidemic of Clostridium difficileAssociated Enteric Disease , 2006, Annals of Internal Medicine.
[122] D. Bratzler. The Surgical Infection Prevention and Surgical Care Improvement Projects: Promises and Pitfalls , 2006, The American surgeon.
[123] Richard Platt,et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[124] Richard Platt,et al. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. , 2006, Archives of internal medicine.
[125] D. Maki,et al. Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit. , 2006, American journal of infection control.
[126] J. Quinn,et al. Multicity Outbreak of Carbapenem-Resistant Acinetobacter baumannii Isolates Producing the Carbapenemase OXA-40 , 2006, Antimicrobial Agents and Chemotherapy.
[127] Jessina C. McGregor,et al. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[128] J. Quinn,et al. First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America , 2006, Antimicrobial Agents and Chemotherapy.
[129] W. Bilker,et al. Reemergence of gram-negative health care-associated bloodstream infections. , 2006, Archives of internal medicine.
[130] G. Saunders. Methicillin resistant Staphylococcus aureus. , 2006, The West Indian medical journal.
[131] L. Rice,et al. Antimicrobial resistance in gram-positive bacteria. , 2006, The American journal of medicine.
[132] A. Standaert,et al. Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links , 2006, BMC infectious diseases.
[133] T. Horan,et al. Ensuring rational public reporting systems for health care-associated infections: systematic literature review and evaluation recommendations. , 2006, American Journal of Infection Control.
[134] R. Weinstein,et al. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[135] T. West,et al. Effect of Targeted Surveillance for Control of Methicillin-Resistant Staphylococcus aureus in a Community Hospital System , 2006, Infection Control & Hospital Epidemiology.
[136] P. Fournier,et al. The epidemiology and control of Acinetobacter baumannii in health care facilities. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[137] M. Bassetti,et al. Epidemiological trends in nosocomial candidemia in intensive care , 2006, BMC infectious diseases.
[138] C. Salgado,et al. What Proportion of Hospital Patients Colonized With Methicillin-Resistant Staphylococcus aureus Are Identified by Clinical Microbiological Cultures? , 2006, Infection Control & Hospital Epidemiology.
[139] S. Cosgrove. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[140] K. Shojania,et al. National Patient Safety Goals. , 2006, Bulletin of the American College of Surgeons.
[141] M. Owings,et al. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. , 2006, Emerging infectious diseases.
[142] 古谷 良輔,et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.
[143] L. Lambert,et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[144] Stuart Johnson,et al. An epidemic, toxin gene-variant strain of Clostridium difficile. , 2005, The New England journal of medicine.
[145] R. Pearse,et al. Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. , 2005, The Journal of hospital infection.
[146] Axel A Brakhage,et al. Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants. , 2005, Current drug targets.
[147] R. Wenzel,et al. Bacteremias: a leading cause of death. , 2005, Archives of medical research.
[148] Michael Y. Lin,et al. Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control Study , 2005, Antimicrobial Agents and Chemotherapy.
[149] Deborah Braccia,et al. Systematic review of economic analyses of health care-associated infections. , 2005, American journal of infection control.
[150] J. Berlin,et al. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[151] Sanjay Saint,et al. Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.
[152] Jon Brazier,et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe , 2005, The Lancet.
[153] Jonathan R Edwards,et al. Overview of nosocomial infections caused by gram-negative bacilli. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[154] A. Panlilio,et al. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[155] R. Bentley. The Development of Penicillin: Genesis of a Famous Antibiotic , 2005, Perspectives in biology and medicine.
[156] M. Klein,et al. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[157] F. Gordin,et al. Reduction in Nosocomial Transmission of Drug-Resistant Bacteria After Introduction of an Alcohol-Based Handrub , 2005, Infection Control & Hospital Epidemiology.
[158] J. Timsit,et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units , 2005, Intensive Care Medicine.
[159] John Quale,et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. , 2005, Archives of internal medicine.
[160] G. Kampf,et al. Efficacy of three ethanol-based hand rubs against feline calicivirus, a surrogate virus for norovirus. , 2005, The Journal of hospital infection.
[161] Stephen R Cole,et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. , 2005, Archives of internal medicine.
[162] Roger Resar,et al. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. , 2005, Joint Commission journal on quality and patient safety.
[163] D. Cardo,et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. , 2005, American journal of infection control.
[164] P. Chou,et al. Impact of Nosocomial Infection on Cost of Illness and Length of Stay in Intensive Care Units , 2005, Infection Control & Hospital Epidemiology.
[165] S. Cosgrove,et al. The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges , 2005, Infection Control & Hospital Epidemiology.
[166] E. Wong,et al. Public Disclosure of Healthcare-Associated Infections: The Role of the Society for Healthcare Epidemiology of America , 2005, Infection Control & Hospital Epidemiology.
[167] Lisa M. Lee,et al. Date of First Positive HIV Test: Reliability of Information Collected for HIV/AIDS Surveillance in the United States , 2005, Public health reports.
[168] J. Gerberding,et al. Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. , 2005, MMWR. Morbidity and mortality weekly report.
[169] R. Glass,et al. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. , 2004, Vaccine.
[170] John Jernigan,et al. The changing face of surveillance for health care-associated infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[171] C. Schultsz,et al. Endemic Multidrug-Resistant Pseudomonas aeruginosa in Critically Ill Patients , 2004, Infection Control & Hospital Epidemiology.
[172] Peter J Pronovost,et al. Eliminating catheter-related bloodstream infections in the intensive care unit* , 2004, Critical care medicine.
[173] William A Rutala,et al. Disinfection and sterilization in health care facilities: what clinicians need to know. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[174] R. Wenzel,et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[175] P. Bradford,et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[176] J. Karlowsky,et al. Factors Associated with Relative Rates of Antibiotic Resistance in Pseudomonas aeruginosa Isolates Tested in Clinical Laboratories in the United States from 1999 to 2002 , 2004, Antimicrobial Agents and Chemotherapy.
[177] D Watling,et al. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. , 2004, The Journal of hospital infection.
[178] Lee H. Harrison,et al. Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program , 2004, Journal of Clinical Microbiology.
[179] Marc-Oliver Wright,et al. Preliminary Assessment of an Automated Surveillance System for Infection Control , 2004, Infection Control & Hospital Epidemiology.
[180] Arnold L. Demain,et al. The β-lactam antibiotics: past, present, and future , 2004, Antonie van Leeuwenhoek.
[181] National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.
[182] G. Ippolito,et al. Nosocomial infections in HIV-positive patients: an overview. , 2003, Infection.
[183] T. Bleck,et al. Implementation of an institutional program to improve clinical and financial outcomes of mechanically ventilated patients: One-year outcomes and lessons learned* , 2003, Critical care medicine.
[184] Nnis System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.
[185] David W Bates,et al. Safety of patients isolated for infection control. , 2003, JAMA.
[186] I. Odenholt,et al. Activity of Three Disinfectants and Acidified Nitrite Against Clostridium difficile Spores , 2003, Infection Control & Hospital Epidemiology.
[187] M. Drancourt,et al. Nosocomial influenza in children. , 2003, The Journal of hospital infection.
[188] Sanjay Saint,et al. Do physicians examine patients in contact isolation less frequently? A brief report. , 2003, American journal of infection control.
[189] D. Henderson. Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting , 2003, Clinical Microbiology Reviews.
[190] R. Lanciotti,et al. Transmission of West Nile virus from an organ donor to four transplant recipients. , 2003, The New England journal of medicine.
[191] O. Kirk,et al. Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study , 2003, AIDS.
[192] Carlene A. Muto,et al. SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus , 2003, Infection Control & Hospital Epidemiology.
[193] R. Wenzel,et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[194] L. Saiman,et al. Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. , 2003, American journal of infection control.
[195] M. Villegas,et al. Acinetobacter Outbreaks, 1977–2000 , 2003, Infection Control & Hospital Epidemiology.
[196] T. Perl,et al. Effect of Nosocomial Vancomycin-Resistant Enterococcal Bacteremia on Mortality, Length of Stay, and Costs , 2003, Infection Control & Hospital Epidemiology.
[197] S. Cosgrove,et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[198] R. Goering,et al. Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. , 2003, The Journal of antimicrobial chemotherapy.
[199] J. Quinn,et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. , 2003, JAMA.
[200] J. Burke,et al. Infection control - a problem for patient safety. , 2003, The New England journal of medicine.
[201] Jianmin Li,et al. Occupationally Acquired Human Immunodeficiency Virus (HIV) Infection: National Case Surveillance Data During 20 Years of the HIV Epidemic in the United States , 2003, Infection Control & Hospital Epidemiology.
[202] M. C. Catalano,et al. Anxiety and Depression in Hospitalized Patients in Resistant Organism Isolation , 2003, Southern medical journal.
[203] A. Nakashima,et al. HIV/AIDS Surveillance in the United States, 1981‐2001 , 2003, Journal of acquired immune deficiency syndromes.
[204] Richard Platt,et al. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[205] S. Cosgrove,et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[206] M. Boeckh,et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.
[207] M. Gardam,et al. Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? , 2002, The Journal of infectious diseases.
[208] Y. Carmeli,et al. Health and economic outcomes of vancomycin-resistant enterococci. , 2002, Archives of internal medicine.
[209] M. Trautmann,et al. Analysis of transmission pathways of Pseudomonas aeruginosa between patients and tap water outlets* , 2002, Critical care medicine.
[210] C. Maslo,et al. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. , 2002, The Journal of hospital infection.
[211] D. Goldmann. Blood-borne pathogens and nosocomial infections. , 2002, The Journal of allergy and clinical immunology.
[212] T. Perl,et al. Pseudo-outbreak of Mycobacterium fortuitum on a Human Immunodeficiency Virus Ward: transient respiratory tract colonization from a contaminated ice machine. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[213] R. Wenzel,et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. , 2002, The New England journal of medicine.
[214] Yansheng Zhang,et al. An outbreak of Mycobacterium chelonae infection following liposuction. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[215] M. Exner,et al. Surveillance for Nosocomial Infections and Fever of Unknown Origin Among Adult Hematology–Oncology Patients , 2002, Infection Control & Hospital Epidemiology.
[216] N. Powe,et al. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes , 2002, Intensive Care Medicine.
[217] Lawrence Corey,et al. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[218] E. Anaissie,et al. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[219] G. Ippolito,et al. Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[220] H. Kantarjian,et al. Masking of Neutropenic Patients on Transport From Hospital Rooms Is Associated With a Decrease in Nosocomial Aspergillosis During Construction , 2002, Infection Control & Hospital Epidemiology.
[221] D. Maki,et al. The Direct Costs of Nosocomial Catheter-Associated Urinary Tract Infection in the Era of Managed Care , 2002, Infection Control & Hospital Epidemiology.
[222] J. Beney,et al. The direct cost and incidence of systemic fungal infections. , 2002, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[223] P. Maurette,et al. [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.
[224] M. Arduino,et al. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002. , 2002, MMWR. Morbidity and mortality weekly report.
[225] K. McDonald,et al. Making health care safer: a critical analysis of patient safety practices. , 2001, Evidence report/technology assessment.
[226] R. Hajjeh,et al. Counterpoint: invasive aspergillosis and the environment--rethinking our approach to prevention. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[227] C. F. von Reyn,et al. Nosocomial infections due to nontuberculous mycobacteria. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[228] D. Snydman,et al. Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study , 2001, Annals of Internal Medicine.
[229] G. Capellier,et al. Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units , 2001, Intensive Care Medicine.
[230] L. Szczech,et al. Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[231] W A Rutala,et al. Lessons From Outbreaks Associated With Bronchoscopy , 2001, Infection Control & Hospital Epidemiology.
[232] M. Field. Tuberculosis in the Workplace , 2001 .
[233] W. Bilker,et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[234] Y. Tselentis,et al. Prospective Evaluation of the Impact of Amoxicillin, Clarithromycin and Their Combination on Human Gastrointestinal Colonization by Candida Species , 2001, Chemotherapy.
[235] J. Rowe,et al. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: Before and after chemoprophylaxis and institution of HEPA filters , 2001, American journal of hematology.
[236] K. Bush,et al. Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.
[237] Gina Pugliese,et al. Nasal Carriage as a Source of Staphylococcus aureus Bacteremia , 2001, Infection Control & Hospital Epidemiology.
[238] M. Libman,et al. Prevalence and Antifungal Susceptibility of 442Candida Isolates from Blood and Other Normally Sterile Sites: Results of a 2-Year (1996 to 1998) Multicenter Surveillance Study in Quebec, Canada , 2001, Journal of Clinical Microbiology.
[239] T. Wright,et al. Acute hepatitis C , 2001, Hepatology.
[240] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[241] S. Hugonnet,et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene , 2000, The Lancet.
[242] Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients , 2000, Biology of Blood and Marrow Transplantation.
[243] C. Hall. Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[244] M. Chamberland,et al. Risk and management of blood-borne infections in health care workers. , 2000, Clinical microbiology reviews.
[245] B. Littenberg,et al. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[246] A. Streifel,et al. Refinements of Environmental Assessment During an Outbreak Investigation of Invasive Aspergillosis in a Leukemia and Bone Marrow Transplant Unit , 2000, Infection Control & Hospital Epidemiology.
[247] T. C. White,et al. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. , 2000, The Journal of infectious diseases.
[248] J. Koplan. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[249] K. Kirkland,et al. Adverse effects of contact isolation , 1999, The Lancet.
[250] J. Hansen,et al. Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses. , 1999, AIDS.
[251] M. Higgins,et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. , 1999, American journal of respiratory and critical care medicine.
[252] D L Campbell,et al. Simulated workplace performance of N95 respirators. , 1999, American Industrial Hygiene Association journal.
[253] D. Smith,et al. Decreased Antimicrobial Resistance after Changes in Antibiotic Use , 1999, Pharmacotherapy.
[254] Stephan Harbarth,et al. Randomized, Placebo-Controlled, Double-Blind Trial To Evaluate the Efficacy of Mupirocin for Eradicating Carriage of Methicillin-Resistant Staphylococcus aureus , 1999, Antimicrobial Agents and Chemotherapy.
[255] Y. Carmeli,et al. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. , 1999, Archives of internal medicine.
[256] W. Bilker,et al. Enterococcal Bacteremia: Risk Factors for Vancomycin Resistance and Predictors of Mortality , 1999, Infection Control & Hospital Epidemiology.
[257] P. Sullivan,et al. Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[258] G. Ippolito,et al. Nosocomial infections in HIV infected patients , 1999 .
[259] D. Cook,et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.
[260] C. F. Masters,et al. Reducing the rate of nosocomially transmitted respiratory syncytial virus. , 1999, American journal of infection control.
[261] P. Francioli,et al. Prevalence and Risk Factors for Nosocomial Infections in Four University Hospitals in Switzerland , 1999, Infection Control & Hospital Epidemiology.
[262] A L Demain,et al. The beta-lactam antibiotics: past, present, and future. , 1999, Antonie van Leeuwenhoek.
[263] Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999. , 1999, MMWR. Morbidity and mortality weekly report.
[264] D. Goldmann,et al. Coagulase-negative staphylococci: role as pathogens. , 1999, Annual review of medicine.
[265] G. Ippolito,et al. Nosocomial infections in HIV infected patients. Gruppo HIV e Infezioni Ospedaliere. , 1999, AIDS.
[266] A. Conde. Staphylococcus aureus infections. , 1998, The New England journal of medicine.
[267] W. Rutala,et al. Pertussis: An Underappreciated Risk for Nosocomial Outbreaks , 1998, Infection Control & Hospital Epidemiology.
[268] D. Cardo,et al. A Case-Control Study of HIV Seroconversion in Health Care Workers After Percutaneous Exposure , 1998 .
[269] R. Ramphal. 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever , 1998 .
[270] R Sylvester,et al. An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. , 1998, The Journal of infection.
[271] P. Kvale,et al. Risk Factors and Outcomes Associated With Identification of Aspergillus in Respiratory Specimens From Persons With HIV Disease , 1998 .
[272] M. Rupp,et al. Environmental Contamination With Vancomycin-Resistant Enterococci in an Outpatient Setting , 1998, Infection Control & Hospital Epidemiology.
[273] J. Rich,et al. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. , 1998, Chest.
[274] J. Bagg,et al. Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[275] C. Flexner,et al. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[276] B. Farr,et al. Disinfection of Hospital Rooms Contaminated With Vancomycin-Resistant Entemcocms faecium , 1998, Infection Control & Hospital Epidemiology.
[277] B. Oppenheim,et al. Hospital-acquired infection in elderly patients. , 1998, The Journal of hospital infection.
[278] P A Gross,et al. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: a consensus panel report. Society for Healthcare Epidemiology of America. , 1998, Infection control and hospital epidemiology.
[279] T. Perl,et al. New Approaches to Reduce Staphylococcus Aureus Nosocomial Infection Rates: Treating S. Aureus Nasal Carriage , 1998, The Annals of pharmacotherapy.
[280] P. Kvale,et al. Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group. , 1998, Chest.
[281] C Brennen,et al. Multiply Antibiotic Resistant Gram-Negative Bacilli in a Long Term Care Facility A Case Control Study of Patient rick Factors and Prior Antibiotic Use , 1997, Infection Control & Hospital Epidemiology.
[282] D. Cardo,et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. , 1997, The New England journal of medicine.
[283] B. Gooch,et al. Occupational Blood Exposures in Dentistry: A Decade in Review , 1997, Infection Control & Hospital Epidemiology.
[284] J. Karlowsky,et al. Candidemia in a Canadian tertiary care hospital from 1976 to 1996. , 1997, Diagnostic microbiology and infectious disease.
[285] J. Brokloff. Enterococcal bacteremia in the surgical intensive care unit: Does vancomycin resistance affect mortality? , 1997 .
[286] G. Schulgen,et al. Incidence and epidemiology of nosocomial infections in patients infected with human immunodeficiency virus. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[287] J. Quivey,et al. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. , 1997, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[288] R. Gaynes,et al. Nosocomial infections in HIV-infected patients: preliminary results from a multicenter surveillance system (1989-1995). , 1997 .
[289] A. van Belkum,et al. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks , 1997, Clinical microbiology reviews.
[290] W. Leisenring,et al. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. , 1997, The Journal of infectious diseases.
[291] L. Chiarello,et al. Management of Healthcare Workers Infected With Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, or Other Bloodborne Pathogens , 1997, Infection Control & Hospital Epidemiology.
[292] MD Janet A. Englund,et al. Respiratory Viral Infections in Immunocompetent and Immunocompromised Persons , 1997, The American Journal of Medicine.
[293] P. Francioli,et al. Nosocomial Infections and Pseudoinfections From Contaminated Bronchoscopes: Two-Year Follow Up Using Molecular Markers , 1997, Infection Control & Hospital Epidemiology.
[294] W. Martone,et al. Outbreak Investigations , 1997, Infection Control & Hospital Epidemiology.
[295] P. Lipsett,et al. Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group. , 1997, Archives of surgery.
[296] R. Wenzel,et al. Prevention and Control of Nosocomial Infections , 1997 .
[297] D. Landman,et al. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[298] K. Edwards,et al. Prevalence and incidence of adult pertussis in an urban population. , 1996, JAMA.
[299] V. Loo,et al. Control of Construction-Associated Nosocomial Aspergillosis in an Antiquated Hematology Unit , 1996, Infection Control & Hospital Epidemiology.
[300] J. Ariza,et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. , 1996, The American journal of medicine.
[301] T. Lundstrom,et al. Controlling Vancomycin-Resistant Enterococci , 1996, Infection Control & Hospital Epidemiology.
[302] M. Alter,et al. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. , 1996, The Journal of infectious diseases.
[303] M. Martell,et al. Transmission of hepatitis C virus by a cardiac surgeon. , 1996, The New England journal of medicine.
[304] W. Rutala. APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc. , 1990, American journal of infection control.
[305] A. Ambergen,et al. Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. , 1996, American journal of respiratory and critical care medicine.
[306] R. Wenzel. The economics of nosocomial infections , 1995 .
[307] M. Nucci,et al. Fungal infections in neutropenic patients. A 8-year prospective study. , 1995, Revista do Instituto de Medicina Tropical de Sao Paulo.
[308] R. Wenzel,et al. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. , 1995, The Journal of hospital infection.
[309] T. Perl,et al. Postoperative wound infections: risk factors and role of Staphylococcus aureus nasal carriage. , 1995, Journal of chemotherapy.
[310] W. Jarvis. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[311] M. Pfaller,et al. Epidemiology of candidiasis. , 1995, The Journal of hospital infection.
[312] L. Hu,et al. Typing of Staphylococcus epidermidis Colonizing in Human Nares by Pulsed‐Field Gel Electrophoresis , 1995, Microbiology and immunology.
[313] J. Bueno,et al. [Fungal infections in neutropenic patients]. , 1995, Sangre.
[314] L. Mermel,et al. Association of Legionnaires Disease with Construction: Contamination of Potable Water? , 1995, Infection Control & Hospital Epidemiology.
[315] A. Catanzaro. Preventing nosocomial transmission of tuberculosis , 1995, The Lancet.
[316] C. Patterson,et al. Joint Commission on Accreditation of Healthcare Organizations. , 1995 .
[317] A. Panlilio,et al. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. , 1995, Journal of the American College of Surgeons.
[318] R. Wenzel. The Lowbury Lecture. The economics of nosocomial infections. , 1995, The Journal of hospital infection.
[319] M. Alter. Occupational Exposure to Hepatitis C Virus: A Dilemma , 1994, Infection Control & Hospital Epidemiology.
[320] R. Wenzel,et al. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[321] C. Marchant,et al. The 1993 epidemic of pertussis in Cincinnati. Resurgence of disease in a highly immunized population of children. , 1994, The New England journal of medicine.
[322] Didier Pittet,et al. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. , 1994, JAMA.
[323] J. Boyce,et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance , 1994, Journal of clinical microbiology.
[324] S. Wilson,et al. Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection. , 1994, Anesthesia and analgesia.
[325] T. Bannerman,et al. Update on clinical significance of coagulase-negative staphylococci , 1994, Clinical Microbiology Reviews.
[326] Vaccination coverage of 2-year-old children--United States, third quarter, 1993. , 1994, MMWR. Morbidity and mortality weekly report.
[327] K. D. de Cock. The new tuberculosis. , 1994, Africa health.
[328] W. Jarvis,et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. , 1995, American journal of infection control.
[329] J. Armitage,et al. Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants , 1993, Infection Control & Hospital Epidemiology.
[330] Fred Silverstein,et al. Transmission of Infection by Gastrointestinal Endoscopy and Bronchoscopy , 1993, Annals of Internal Medicine.
[331] L. Herwaldt,et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[332] P. Madge,et al. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus , 1992, The Lancet.
[333] B. Farber,et al. Percutaneous injuries during surgical procedures. , 1992, JAMA.
[334] C Y Ou,et al. Transmission of Human Immunodeficiency Virus in a Dental Practice , 1992 .
[335] H. Pohle,et al. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. , 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.
[336] G. Eliopoulos,et al. Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution , 1991, Antimicrobial Agents and Chemotherapy.
[337] W. Craig,et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[338] S. Banks,et al. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. , 1991, The American journal of medicine.
[339] L. Young,et al. GUIDELINES FROM THE INFECTIOUS DISEASES SOCIETY OF AMERICA 1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever , 1997 .
[340] Occupational exposure to bloodborne pathogens--OSHA. Final rule. , 1991, Federal register.
[341] J. Shenep,et al. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. , 1991, The Journal of infectious diseases.
[342] Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. , 1991, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[343] W A Rutala,et al. APIC guideline for selection and use of disinfectants. , 1996, American journal of infection control.
[344] G. Coles,et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. , 1990, The New England journal of medicine.
[345] H. Ahlers,et al. Occupational Safety and Health Standards , 1989, Annals of the New York Academy of Sciences.
[346] F. Mandelli,et al. Candida colonization and systemic infection in neutropenic patients. A retrospective study , 1989, Cancer.
[347] R. Woolson,et al. Risk factors for hospital-acquired candidemia. A matched case-control study. , 1989, Archives of internal medicine.
[348] L. Peterson,et al. Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure , 1989, Journal of clinical microbiology.
[349] T. Rogers,et al. Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. , 1989, The Journal of hospital infection.
[350] M. Savitz. Efficacy of antibiotic prophylaxis. , 1989, Neurosurgery.
[351] K. Cummings,et al. Incidence of Nosocomial Aspergillosis in Patients with Leukemia Over a Twenty-Year Period , 1989, Infection Control & Hospital Epidemiology.
[352] P. Collignon. Coagulase-negative staphylococcal bacteremia. , 1989, Annals of internal medicine.
[353] B. Yangco,et al. CDC definitions for nosocomial infections. , 1989, American journal of infection control.
[354] W. Stamm,et al. Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.
[355] M. A. Martin,et al. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. , 1989, Annals of internal medicine.
[356] R. Rubin,et al. Invasive aspergillus infection: possible non-ward common source within the hospital environment. , 1989, The Journal of hospital infection.
[357] M. Schurgers,et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[358] J M Hughes,et al. CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.
[359] J. Hughes,et al. Study on the efficacy of nosocomial infection control (SENIC Project): results and implications for the future. , 1988, Chemotherapy.
[360] S. Solomon,et al. Health and economic impacts of antimicrobial resistance. , 1987, Reviews of infectious diseases.
[361] B. Kramer,et al. Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. , 1987, The American journal of medicine.
[362] M. Piens,et al. Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works , 1987, Epidemiology and Infection.
[363] D. Goldmann,et al. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions. , 1987, The New England journal of medicine.
[364] C B Hall,et al. Respiratory syncytial viral infection in children with compromised immune function. , 1986, The New England journal of medicine.
[365] V. Yu,et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. , 1986, The New England journal of medicine.
[366] J. Hughes,et al. Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. , 1985, American journal of infection control.
[367] R. Haley,et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. , 1985, American journal of epidemiology.
[368] R A Weinstein,et al. Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. , 1984, The Journal of infectious diseases.
[369] R. Wenzel,et al. Hospital-Acquired Infections in Intensive Care Unit Patients An Overview with Emphasis on Epidemics , 1983, Infection Control.
[370] G. Grady,et al. Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. , 1982, Annals of internal medicine.
[371] J. Bartlett,et al. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. , 1981, Gastroenterology.
[372] D. Quade,et al. The SENIC Project. Study on the efficacy of nosocomial infection control (SENIC Project). Summary of study design. , 1980, American journal of epidemiology.
[373] K. Pavri. Neonatal respiratory-syncytial-virus infection. , 1979, The New England journal of medicine.
[374] J. Senior,et al. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. , 1978, The Journal of infectious diseases.
[375] Arnow Pm,et al. Pumonary aspergillosis during hospital renovation. , 1978 .
[376] P. Arnow,et al. Pumonary aspergillosis during hospital renovation. , 1978, The American review of respiratory disease.
[377] A. Seaton,et al. Sources and incidence of airborne Aspergillus fumigatus (Fres) , 1976, Clinical allergy.
[378] R. Wenzel,et al. Hospital-acquired infections. I. Surveillance in a university hospital. , 1976, American journal of epidemiology.
[379] R. Douglas,et al. Nosocomial respiratory syncytial virus infections. , 1975, The New England journal of medicine.
[380] J. McCormick,et al. USE OF PERTUSSIS VACCINE IN AN EPIDEMIC INVOLVING HOSPITAL STAFF , 1975, The Lancet.
[381] R. Purcell,et al. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. , 1972, Annals of internal medicine.
[382] D. Feingold,et al. Hospital-acquired infections. , 1970 .
[383] J. Enders,et al. Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.